216 related articles for article (PubMed ID: 31921860)
1. Long Non-coding RNA LINC-PINT Suppresses Cell Proliferation and Migration of Melanoma via Recruiting EZH2.
Xu Y; Wang H; Li F; Heindl LM; He X; Yu J; Yang J; Ge S; Ruan J; Jia R; Fan X
Front Cell Dev Biol; 2019; 7():350. PubMed ID: 31921860
[TBL] [Abstract][Full Text] [Related]
2. lncRNA LINC-PINT is downregulated in melanoma and regulates cell proliferation by downregulating lncRNA BANCR.
Huang Q; Zhang D; Diao Q; Lin M
Oncol Lett; 2019 Sep; 18(3):2917-2922. PubMed ID: 31452772
[TBL] [Abstract][Full Text] [Related]
3. LINC-PINT suppresses breast cancer cell proliferation and migration via MEIS2/PPP3CC/NF-κB pathway by sponging miR-576-5p.
Li D; Hu A
Am J Med Sci; 2024 Mar; 367(3):201-211. PubMed ID: 37660994
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA
Duan J; Ma X; Shi J; Xuan Y; Wang H; Li P; Zhang Y; Fan Y; Gong H; Ma X; Pang Y; Wang L; Yan Y; Zhang X
Onco Targets Ther; 2019; 12():4729-4740. PubMed ID: 31417274
[No Abstract] [Full Text] [Related]
5. Long noncoding RNA LINC-PINT inhibits non-small cell lung cancer progression through sponging miR-218-5p/PDCD4.
Zhang L; Hu J; Li J; Yang Q; Hao M; Bu L
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1595-1602. PubMed ID: 31010333
[TBL] [Abstract][Full Text] [Related]
6. Long Noncoding RNA LINC-PINT Suppresses Cell Proliferation, Invasion, and EMT by Blocking Wnt/β-Catenin Signaling in Glioblastoma.
Zhu H; Chen Z; Shen L; Tang T; Yang M; Zheng X
Front Pharmacol; 2020; 11():586653. PubMed ID: 33505307
[No Abstract] [Full Text] [Related]
7. LncRNA Linc-PINT inhibits miR-523-3p to hamper retinoblastoma progression by upregulating Dickkopf-1 (DKK1).
Zhou X; Wang Y; Li Q; Ma D; Nie A; Shen X
Biochem Biophys Res Commun; 2020 Sep; 530(1):47-53. PubMed ID: 32828314
[TBL] [Abstract][Full Text] [Related]
8. LINC-PINT suppresses cisplatin resistance in gastric cancer by inhibiting autophagy activation
Zhang C; Kang T; Wang X; Wang J; Liu L; Zhang J; Liu X; Li R; Wang J; Zhang J
Front Pharmacol; 2022; 13():968223. PubMed ID: 36091809
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of long non-coding RNA LINC-PINT serves as a diagnostic and prognostic biomarker in patients with non-small cell lung cancer.
Zhang C; Gong C; Li J; Tang J
Oncol Lett; 2021 Mar; 21(3):210. PubMed ID: 33552292
[TBL] [Abstract][Full Text] [Related]
10. LINC-PINT Suppresses the Aggressiveness of Thyroid Cancer by Downregulating miR-767-5p to Induce TET2 Expression.
Jia M; Li Z; Pan M; Tao M; Wang J; Lu X
Mol Ther Nucleic Acids; 2020 Dec; 22():319-328. PubMed ID: 33230437
[TBL] [Abstract][Full Text] [Related]
11. [LncRNA LINC-PINT regulating proliferation and apoptosis of osteosarcoma cells by targeting miR-524-5p].
Yang H; Cao C; Wang LJ
Zhonghua Zhong Liu Za Zhi; 2020 Apr; 42(4):325-330. PubMed ID: 32375449
[No Abstract] [Full Text] [Related]
12. LncRNA LINC-PINT Inhibits Cancer Cell Proliferation, Invasion, and Migration in Osteosarcoma by Downregulating miRNA-21.
Liu W
Cancer Biother Radiopharm; 2019 May; 34(4):258-263. PubMed ID: 31070482
[No Abstract] [Full Text] [Related]
13. Deregulation of
Garitano-Trojaola A; José-Enériz ES; Ezponda T; Unfried JP; Carrasco-León A; Razquin N; Barriocanal M; Vilas-Zornoza A; Sangro B; Segura V; Prósper F; Fortes P; Agirre X
Oncotarget; 2018 Feb; 9(16):12842-12852. PubMed ID: 29560114
[TBL] [Abstract][Full Text] [Related]
14. Long intragenic non-coding RNA p53-induced transcript (LINC-PINT) as a novel prognosis indicator and therapeutic target in cancer.
He T; Yuan C; Zhao C
Biomed Pharmacother; 2021 Nov; 143():112127. PubMed ID: 34474342
[TBL] [Abstract][Full Text] [Related]
15. LncRNA AGAP2-AS1 Promotes Cancer Cell Proliferation, Migration and Invasion in Colon Cancer by Forming a Negative Feedback Loop with LINC-PINT.
Ji L; Chen S; Gu L; Wang J; Zhang X
Cancer Manag Res; 2021; 13():2153-2161. PubMed ID: 33688258
[TBL] [Abstract][Full Text] [Related]
16. Up regulation of long non-coding RNAs BACE1 and down regulation of LINC-PINT are associated with CRC clinicopathological characteristics.
Bakhtiari-Nezhad S; Rejali L; Hadizadeh M; Taleghani MY; Aghdaei HA; Young C; Khanabadi B; Nazemalhosseini-Mojarad E; Bonab MA
Mol Biol Rep; 2022 Nov; 49(11):10259-10267. PubMed ID: 36087249
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA LINC-PINT is inhibited in gastric cancer and predicts poor survival.
Feng H; Zhang J; Shi Y; Wang L; Zhang C; Wu L
J Cell Biochem; 2019 Jun; 120(6):9594-9600. PubMed ID: 30569513
[TBL] [Abstract][Full Text] [Related]
18. LINC-PINT Inhibited Malignant Progression of Bladder Cancer by Targeting miR-155-5p.
Han X; Liu J; Liu Y; Mou L; Li C
Cancer Manag Res; 2021; 13():4393-4401. PubMed ID: 34103994
[TBL] [Abstract][Full Text] [Related]
19. Linc-pint inhibits early stage pancreatic ductal adenocarcinoma growth through TGF-β pathway activation.
Lu H; Yang D; Zhang L; Lu S; Ye J; Li M; Hu W
Oncol Lett; 2019 May; 17(5):4633-4639. PubMed ID: 30944652
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA LINC-PINT attenuates paclitaxel resistance in triple-negative breast cancer cells via targeting the RNA-binding protein NONO.
Chen J; Zhu M; Zou L; Xia J; Huang J; Deng Q; Xu R
Acta Biochim Biophys Sin (Shanghai); 2020 Aug; 52(8):801-809. PubMed ID: 32632453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
